{"nct_id":"NCT02913261","title":"Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2017-03-10","start_date_type":"ACTUAL","primary_completion_date":"2019-06-24","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}